RxSight: Pay

RxSight paid its 5 named executives $14.6M in total in FY2025 (Dec). CEO Ron Kurtz, M.D. was paid $4.7M of that.

Pay$100 in the stock at the end of FY21 → $93
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Ron Kurtz, M.D.Chief Executive Officer, President and Director
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Eric WeinbergChief Business Development Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Shelley ThunenFormer Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Ilya Goldshleger, Ph.D.Chief Operating Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Scott GainesChief Customer Officer
FY2025 (Dec)
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 11 peers with pay on file was $9.2M. CEO pay of RxSight for that year is not on file.

  1. 1Twist Bioscience
  2. 2GLAUKOS
  3. 3TransMedics Group
  4. 4Alphatec Holdings
  5. 5Adma Biologics
  6. 6AtriCure
  7. 7Inspire Medical Systems
  8. 8Staar Surgical
  9. 9Veracyte
  10. 10Artivion
  11. 11Orthopediatrics
  12. 12RxSightNot disclosed
  13. 13Axonics, Inc.Not disclosed
  14. 14Inari Medical, Inc.Not disclosed
  15. 15Lemaitre VascularNot disclosed
  16. 16PROCEPT BioRoboticsNot disclosed
  17. 17SI-BONE, Inc.Not disclosed
  18. 18Silk Road Medical, Inc.Not disclosed
  19. 19VericelNot disclosed
  20. 20iRhythm Technologies, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.